News Release: Hemedex, Inc. Receives FDA Clearance for the QFlow 500™ Titanium Bolt – Quad Lumen Bolt Kit

Posted by on Oct 13, 2014 in News Releases

News Release: Hemedex, Inc. Receives FDA Clearance for the QFlow 500™ Titanium Bolt – Quad Lumen Bolt Kit

CAMBRIDGE, Mass. (October 13, 2014) –Hemedex, Inc. is pleased to announce the market release of its new Quad Lumen Bolt Kit as an addition to its cranial bolt product line. The QFlow 500™Titanium Bolt Kits -single, dual and now quad lumen- secure the minimally invasive QFlow 500™ Perfusion Probe through a burr hole in the cranium.

 

The Quad Lumen Bolt Kit is the optimal solution for a user that seeks to secure the Hemedex probe and up to three other sensors through a single burr hole, thus co-localizing multiple neurophysiological parameters.  This product meets the need of multi-port access in the growing field of Multi-Modal Monitoring.  All Hemedex bolts are made with titanium bodies, are CT compatible, and are easy to place requiring no additional tools to insert or remove the bolt other than a drill.

quad for news release

QFlow 500™ Titanium Bolt -Quad Lumen

 

The QFlow 500™ Titanium Bolt -Quad Lumen Bolt Kit includes a quad lumen bolt, 5.3mm drill bit, depth collar, hex wrench, compression fittings, sealing caps, stylets, sensor introducers, scalpel, and a pigtail extension.

For pricing and order information please contact salesteam@hemedex.com. For more information on the cranial bolts please visit http://hemedex.com/products/overview/.

Communications Team
Hemedex Inc.
sblair@hemedex.com
617 577 1759 X 46

 

About Hemedex, Inc.:

Hemedex, Inc. manufactures patient monitoring technology, the Bowman Perfusion Monitor®, for quantifying tissue blood flow. The Company’s patented technology provides clinicians with a powerful tool, which can provide an early warning of compromised blood flow and help target appropriate therapies rapidly and accurately. Data from the Bowman Perfusion Monitor helps guide physicians in implementing effective treatments quickly, creating the potential to improve patient outcomes and lower costs. Hemedex’s technology addresses unmet needs in many clinical areas such as neurocritical care (e.g., TBI, SAH), neurosurgery (e.g., TAO, EC-IC Bypass, Moya Moya), reconstructive surgery and organ transplantation, among others.  For more information, visit www.hemedex.com.